Literature DB >> 8172704

Acute low-tone sensorineural hearing loss without vertigo.

T Yamasoba1, S Kikuchi, M Sugasawa, M Yagi, T Harada.   

Abstract

OBJECTIVE: To study the pathophysiological features of acute low-tone sensorineural hearing loss without vertigo (ALHL) and its correlation with Meniere's disease.
DESIGN: Retrospective review of medical charts of patients with ALHL.
SETTING: University hospital clinic. PARTICIPANTS: Eighty consecutive patients with ALHL, including 45 patients whose conditions were followed up for more than 3 years (average, 5 years 2 months; range, 3 years 3 months to 8 years). OUTCOME MEASURES: Age and sex distributions and results of audiological and neuro-otological tests, initial outcome, recurrence rates, and differences between patients with and without recurrence.
RESULTS: About 75% (62/80) of the patients were between the ages of 30 and 60 years and the female-male ratio was 2:6. Positive glycerol test results were found in 74% (26/35) of patients and abnormally increased negative summating potential/action potential ratio in 63% (50/80). No abnormalities were found on neuro-otological tests. Hearing loss improved within 3 months in 84% (67/80) of the patients. Of 45 patients followed up for more than 3 years, 28 (62%) showed no evidence of recurrence, 12 (27%) developed cochlear Meniere's disease, and five (11%) developed classic Meniere's disease. No significant differences were found at the first examination between patients with and without recurrence.
CONCLUSIONS: These results suggest that ALHL may be caused by endolymphatic hydrops confined to the cochlea and that ALHL does not always lead to cochlear or classic Meniere's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172704     DOI: 10.1001/archotol.1994.01880290042007

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  [Low frequency fluctuating hearing loss without labyrinthine vertigo--a genuine disease? A follow up study after 4 and 10 years].

Authors:  H Schaaf; G Hesse
Journal:  HNO       Date:  2007-08       Impact factor: 1.284

Review 2.  [Management of the patient with Meniere's disease. Clear diagnosis but vertigo-provoking perspective].

Authors:  H Schaaf; H Holtmann
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

3.  Use of intratympanic dexamethasone for the therapy of low frequency hearing loss.

Authors:  Necat Alatas
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-20       Impact factor: 2.503

4.  Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo.

Authors:  Myung Jin Park; Sang Hoon Kim; Sung Su Kim; Seung Geun Yeo
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-01-10       Impact factor: 3.372

5.  Comorbid Symptoms Occurring During Acute Low-Tone Hearing Loss (AHLH) as Potential Predictors of Menière's Disease.

Authors:  Katharina Stölzel; Judith Droste; Linda Josephine Voß; Heidi Olze; Agnieszka J Szczepek
Journal:  Front Neurol       Date:  2018-10-29       Impact factor: 4.003

6.  Low-Frequency Sensorineural Hearing Loss Associated With Iron-Deficiency Anemia.

Authors:  Masakatsu Taki; Tatsuhisa Hasegawa; Yuzuru Ninoyu; Hiroaki Mohri; Shigeru Hirano
Journal:  J Int Adv Otol       Date:  2021-09       Impact factor: 1.017

7.  Combination Therapy and Single-Modality Treatment for Acute Low-Tone Hearing Loss: A Meta-Analysis with Trial Sequential Analysis.

Authors:  Jing-Li Leong; Chih-Hao Chen; Chii-Yuan Huang; Hsiu-Lien Cheng; Yuan-Chia Chu; Chun-Yu Chang; Yen-Fu Cheng
Journal:  Brain Sci       Date:  2022-06-30

8.  Long-Term Outcomes of Acute Low-Tone Hearing Loss.

Authors:  Kyung Jin Roh; Eun Jung Lee; Ah Young Park; Byeong Il Choi; Eun Jin Son
Journal:  J Audiol Otol       Date:  2015-09-16

9.  Short-Term Outcomes of Acute Low-Tone Sensorineural Hearing Loss According to Treatment Modality.

Authors:  Jinkyung Chang; Gunhwee Yum; Ha-Young Im; Jong Yoon Jung; Yoon Chan Rah; June Choi
Journal:  J Audiol Otol       Date:  2016-04-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.